lobbying_activities: 923762
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 923762 | 4f846afd-7f85-4534-838f-43497532f14b | Q1 | THE DUBERSTEIN GROUP INC. | 12675 | NORVARTIS CORP | 2010 | first_quarter | PHA | Healthcare reform, including follow-on biologics and other pharmaceutical provisions - HR 3962, To provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes; HR 3590, An act entitled The Patient Protection and Affordable Care Act; HR 4872, Health Care and Education Reconciliation Act of 2010. | HOUSE OF REPRESENTATIVES,SENATE | 100000 | 0 | 0 | 2010-04-19T16:09:21.160000-04:00 |